Pacific Biosciences Of California (PACB) Net Income Growth (3y) (2013 - 2026)
Pacific Biosciences Of California (PACB) Net Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -2.19% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 2.38% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 343.24% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 60.12% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Pacific Biosciences Of California | 402.15 Mn | 126.19 Mn | 12.84 Mn | 54.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.53% |
| Dec 31, 2025 | 21.79% |
| Sep 30, 2025 | 20.97% |
| Jun 30, 2025 | 16.26% |
| Mar 31, 2025 | -73.56% |
| Dec 31, 2024 | 26.71% |
| Jun 30, 2024 | -61.48% |
| Mar 31, 2024 | -30.10% |
| Dec 31, 2023 | -45.72% |
| Sep 30, 2023 | -41.29% |
| Jun 30, 2023 | -43.72% |
| Mar 31, 2023 | -38.71% |
| Dec 31, 2022 | -65.56% |
| Sep 30, 2022 | -38.81% |
| Jun 30, 2022 | -41.83% |
| Mar 31, 2022 | -38.38% |
| Dec 31, 2021 | -30.42% |
| Jun 30, 2021 | -22.59% |
| Mar 31, 2021 | -13.11% |
| Dec 31, 2020 | 76.97% |